MODERATE PLAQUE PSORIASIS
Clinical trials for MODERATE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Head-to-Head: which psoriasis drug comes out on top?
Disease control CompletedThis study compared two approved medications, risankizumab (injections every 12 weeks) and deucravacitinib (daily pills), in 393 adults with moderate plaque psoriasis. The goal was to see which treatment better clears skin and reduces symptoms. Participants were not previously tr…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
New hope for stubborn psoriasis: drug clears skin in Hard-to-Treat areas
Symptom relief CompletedThis study tested a drug called guselkumab against a placebo in 338 adults with moderate plaque psoriasis that also affects special sites like the scalp, nails, or genitals. The goal was to see if the drug could clear or nearly clear the psoriasis in those areas. Results showed t…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC